Clinical Trial

Combatting HIV Or Other STIs Early (CHOOSE)

Study acronym: CHOOSE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2029-09 -> 2029-03-30 2026-07-14
minor Completion moved earlier: 2029-09 -> 2029-03-30 2026-07-14
Trial Details
NCT Number NCT07510048
Lead Sponsor Westat
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), National Institutes of Health (NIH), Florida State University, The Emmes Company, LLC
Conditions HIV, STIs, STIs Prevention, HIV Prevention
Enrollment 200 participants
Start Date 2026-07-20
Primary Completion 2029-03-30 (estimated)
Study Completion 2029-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-13